课题基金 / 基金详情

项目摘要

项目成果

DAVID HERLIE ROBERTSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Oral ingestion of water greatly elevates blood pressure in individuals with impaired autonomic reflexes. While the effect averages 30-40 mmHg, there is large interindividual variation with occasional increases of 100 mmHg. We were initially startled by the magnitude of this response, but others have now replicated it and confirmed its magnitude. An effect is also found in treated hypertensive subjects and in normal subjects, albeit it at smaller magnitude. We have also found that ingestion of water potentiates the effect of the pressor drug phenylpropanolamine (PPA). In view of its magnitude and robustness, the pressor response to water may signal an important but heretofore unrecognized mechanism at work in human cardiovascular regulation both in health and disease. The water response may have important diagnostic and therapeutic implications. In particular, it may be the major unrecognized determinant of noise in blood pressure assessment in the older population, and might possibly be a source of interindividual and intraindividual variation in orthostatic tolerance. The purpose of this proposal is to address the mechanism of the cardiovascular effect of water ingestion, and address the basis of interindividual variation in this gastropressor response. We seek to understand if the sympathetic nervous system is mediating water's pressor response in Specific Aim 1. In Specific Aim 2, we try to determine the macroscopic stimulus underlying the response. In Specific Aims 3 and 4, we address potential efferent mechanisms at a more molecular level in both human subjects and in a mouse model system. Finally in Specific Aim 5 we try to determine the basis of the age dependency of the pressor response to water. Although water is a part of daily life, we believe the gastropressor response we have observed may have important consequences in health and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADMINISTRATIVE CORE
  • 批准号:
    8147954
  • 项目类别:
  • 资助金额:
    $11.98万
  • 财政年份:
    2010
  • 负责人:
    DAVID HERLIE ROBERTSON
  • 依托单位:
Echocardiograph and Vascular Doppler
  • 批准号:
    7794037
  • 项目类别:
  • 资助金额:
    $20.14万
  • 财政年份:
    2010
  • 负责人:
    DAVID HERLIE ROBERTSON
  • 依托单位:
AUTONOMIC DETERMINANTS OF ORTHOSTATIC TOLERANCE
  • 批准号:
    8147945
  • 项目类别:
  • 资助金额:
    $31.86万
  • 财政年份:
    2010
  • 负责人:
    DAVID HERLIE ROBERTSON
  • 依托单位:
Autonomic Rare Diseases Clinical Research Consortium
  • 批准号:
    8136818
  • 项目类别:
  • 资助金额:
    $13.95万
  • 财政年份:
    2009
  • 负责人:
    DAVID HERLIE ROBERTSON
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: